Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Activists recently filed disclosures with the SEC that included Privia Health Group (PRVA), putting fresh attention on the physician-enablement specialist and how its shares trade around the latest ownership updates. At around US$19.85 per share, Privia Health Group has been under pressure, with the share price falling 6.4% over the past month and 16.1% over the last quarter. The 1-year total shareholder return is down 11.3%, pointing to fading momentum that may reflect investors reassessing...
Privia Health Group shares most recently closed at US$19.85, and the weaker run in the stock raises a straightforward question for investors who care about valuation. Is the current price fully supported by the earnings profile of Privia Health Group, or has sentiment moved further than the underlying profit story? Over the past 5 years the share price has fallen 23.1%, which puts the focus firmly on whether the current earnings justify staying invested or stepping in now. The business model...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Activists report to the SEC on Privia Health Group, Group 1 Automotive, MarineMax, OrthoPediatrics, and Dell Technologies.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.